References
- Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, Goldman ND, Acostamadiedo JM, Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48(3):425–429.
- Chen JG, Fleischer AB Jr, Smith ED, Kancler C, Goldman ND, Williford PM, Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27(12):1035–1038.
- Hansen C, Wilkinson D, Hansen M, Argenziano G. How good are skin cancer clinics at melanoma detection? Number needed to treat variability across a national clinic group in Australia. J Am Acad Dermatol. 2009;61(4):599–604.
- Green AR, Elgart GW, Ma F, Federman DG, Kirsner RS. Documenting dermatology practice: Ratio of cutaneous tumors biopsied that are malignant. Dermatol Surg. 2004;30(9):1208–1209.
- Soares TF, Laman SD, Yiannias JA, Connolly SM, Lim KK, Wu Q, Factors leading to the biopsy of 1547 pigmented lesions at Mayo Clinic, Scottsdale, Arizona, in 2005. Int J Dermatol. 2009;48(10):1053–1056.